Pharma - Pharma Rep Focus

Senate unanimously endorses legislation targeting pharma 'patent thickets'

Fierce Pharma

JULY 11, 2024

Even as pharma companies have yet to feel the full effects of the Inflation Reduction Act, Senate lawmakers have turned their attention to another facet of drug pricing with a bill meant to cr | The bill looks to limit the number of patents that companies can assert in litigation on individual products.

Pharma

Pharma Competition

Grünenthal continues US growth push with $250M acquisition of Valinor Pharma

Fierce Pharma

JULY 22, 2024

Grünenthal has continued its expansion splurge, | Grünenthal has continued its expansion splurge, acquiring Valinor Pharma and its lone commercial product Movantik (naloxegol), a treatment for opioid-induced constipation (OIC), for $250 million.

Pharma

Fierce Pharma Asia—Hengrui's FDA reprimands; Sanofi's India site expansion; Aslan's downfall

Fierce Pharma

JULY 19, 2024

A 10-page Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind a recent FDA rejection. A 10-observation Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind its recent FDA rejection. Singapore biotech Aslan Pharma is winding down. And more.

Pharma

Pharma FDA

Pharma companies report different impacts from IT outrage caused by CrowdStrike, Microsoft

Fierce Pharma

JULY 19, 2024

While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown | While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at (..)

Pharma

Bayer to largely complete layoffs within pharma commercial team in 2024, exec says

Fierce Pharma

JULY 9, 2024

Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team, shaking up its structure, personnel and operations. Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team.

Pharma

Fierce Pharma Asia—Big Pharma's search for China deals; Enhertu slowdown; A Samsung Bio record

Fierce Pharma

JULY 25, 2024

Large pharma companies are still looking for deals in China. Large pharma companies are still looking for deals in China. AstraZeneca and Daiichi Sankyo's antibody-drug conjugate star Enhertu experienced a slow quarter. AstraZeneca and Daiichi Sankyo's ADC star Enhertu slowed down.

Pharma

Using AI to Become Pharma's Next Superhero

Fierce Pharma

NOVEMBER 20, 2023

“AI is becoming part of the pharma fabric, and it really is set to disrupt the industry.” | Viz.ai’s Nina Binetti is joined by colleagues at CrowdPharm and Remedy Product Studio to explore the various ways in which AI is being used among pharma companies – from improving patient diagnoses and treatments to unlocking operating efficiencies.

Pharma

Pharma Patients

NS Pharma's Duchenne therapy Viltepso fails confirmatory trial

Fierce Pharma

MAY 28, 2024

Since NS Pharma launched its Duchenne muscular dystrophy (DMD) drug Viltepso (viltolarsen) in 2020, sales have steadily

Pharma

Pharma Sales

Executive Interviews at Digital Pharma East 2023

Fierce Pharma

OCTOBER 11, 2023

Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Learn more by watching the videos below.

Pharma

Pharma Marketing

Fierce Pharma Asia—AbbVie's TL1A deal; Ex-Takeda staffer's guilty plea; Kyowa Kirin's $530M plant investment

Fierce Pharma

JUNE 13, 2024

Through a licensing deal with a Chinese biotech, AbbVie is the latest Big Pharma to bet on TL1A in immunology. Through a deal with a Chinese biotech, AbbVie is the latest Big Pharma to bet on TL1A in immunology. A former Takeda employee has pleaded guilty to scamming the Japanese drugmaker.

Pharma

Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced

Fierce Pharma

NOVEMBER 28, 2023

Gilead Sciences' Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce. Gilead’s Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce.

Pharma

Leo Pharma prepares to come for the topical JAK market as Incyte's Opzelura cream launch cools off

Fierce Pharma

MAY 3, 2024

Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. | Leo Pharma's delgocitinib, which the company calls a potential growth driver, could shake up the topical JAK market and put pressure on Incyte's approved Opzelura.

Pharma

Pharma Marketing

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

Fierce Pharma

NOVEMBER 20, 2023

s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. s drug pricing policy, the pharma industry has secured an improved government spending deal. After blasting the U.K.’s After blasting the U.K.’s

Government

Government Pharma Prescription

2024 forecast: Big Pharma reworks China strategy, and job cuts are part of it

Fierce Pharma

DECEMBER 21, 2023

Big Pharma companies have often talked about the major opportunities that await in China. | Big Pharma companies have often talked about the major opportunities that await in China. But as price cuts play out and internal priorities shift, multinational companies are reworking their business models in the country.

Pharma

Pharma marketing: Getting personalized with Fingerpaint Group

Fierce Pharma

OCTOBER 9, 2023

Marketers operating in every sector are seeking ways to offer personalized, high-quality experiences to their target audiences. | How much influence will AI exert over pharma marketing? Fingerpaint Group’s Paul Hagopian sits down with Fierce Pharma to discuss what has become a hotly contested topic.

Marketing

Marketing Pharma

Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans

Fierce Pharma

DECEMBER 20, 2023

Following an IPO and ahead of its fiscal 2023 earnings release next month, German drug containment and delivery specialist Schott Pharma is trumpeting its recent momentum. | Following an IPO and ahead of its fiscal 2023 earnings release next month, pharma glass specialist Schott Pharma is trumpeting its recent momentum.

Pharma

Pharma Sales

Tris Pharma captures FDA nod for non-stimulant ADHD treatment Onyda XR

Fierce Pharma

MAY 29, 2024

Tris Pharma has won FDA approval for Onyda XR (clonidine hydrochloride). Stimulants are typically the go-to option for doctors prescribing treatments for attention-deficit hyperactivity disorder (ADHD).

Pharma

Pharma FDA Doctors Medical

With exec appointments and new pharma unit, Bayer's overhaul takes shape

Fierce Pharma

MARCH 20, 2024

In the pharma sector, Bayer revealed a new Global Commercialization unit, which will be led by Christine Roth. .” | Early this month at an investor event, Bayer CEO Bill Anderson declared that employees “are ready for change." " On Wednesday, Anderson answered the call with changes to the company’s leadership.

Pharma

Eying Incyte's Opzelura, Leo Pharma shares data for JAK cream in hand eczema

Fierce Pharma

OCTOBER 13, 2023

Back in February, Leo Pharma revealed that its JAK-inhibitor cream delgocitinib met its primary and secondary endpoints in a phase 3 trial in chronic hand eczema, putting pressure on Incyte’s appro | Back in February, Leo Pharma revealed that its JAK-inhibitor cream delgocitinib met its primary and secondary endpoints in a phase 3 trial in chronic (..)

Pharma

Fierce Pharma Asia—Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament

Fierce Pharma

MARCH 28, 2024

Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. AstraZeneca is working to separate its supply chains for the U.S. AstraZeneca is working to separate its supply chains for the U.S. and China.

Pharma

Pharma Marketing

Fierce Pharma Asia—Plant expansions at Novo, Novartis, Merck KGaA; Kyowa Kirin's pricing record; BeiGene's PD-1 nod

Fierce Pharma

MARCH 21, 2024

Three large pharma companies plan to expand their manufacturing footprints. Three large pharma companies plan to expand their manufacturing footprints. Kyowa Kirin’s $4.25 million gene therapy set a new world pricing record. Kyowa Kirin’s $4.25 million gene therapy set a new world pricing record.

Pharma

Pharma Manufacturing FDA

'The Top Line': A look at pharma revenue rankings

Fierce Pharma

APRIL 25, 2024

Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Staff Writer Kevin Dunleavy are diving into our annual top pharma companies by revenue special report.

Pharma

Pharma Specialization

J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings

Fierce Pharma

MARCH 13, 2024

million in his first year as CEO, the pharma giant more than doubled his compensation to $28.4 It didn’t take long for Johnson & Johnson CEO Joaquin Duato to catch up to his predecessor. | It didn’t take long for Johnson & Johnson CEO Joaquin Duato to catch up to his predecessor. After paying Duato $13.1

Pharma

Vanda, after rejecting Future Pak offer, gets $466M takeout bid from Cycle Pharma

Fierce Pharma

JUNE 6, 2024

England-based rare disease drug maker Cycle Pharma revealed an $8-per-share offer for Vanda, representing a total buyout offer of $466 million.

Pharma

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Fierce Pharma

NOVEMBER 21, 2023

Federal Trade Commission isn’t letting up in its effort to crack down on pharma’s alleged misuse of a patent mechanism in the FDA’s regulatory process. | Federal Trade Commission isn't letting up in its effort to crack down on pharma's alleged misuse of a patent mechanism in the FDA's regulatory process.

Pharma

Pharma FDA

Novo attempts to parry Sanders' GLP-1 pricing complaints by calling out pharma middlemen

Fierce Pharma

MAY 29, 2024

In a recent letter to the Senate HELP committee, Novo blamed so-called pharma middlemen for the steep costs of its diabetes and obesity blockbusters, Bloomberg reports. The company said it only keeps around 60% of the list price of Ozempic and Wegovy in the U.S. after paying out rebates and fees to middlemen.

Pharma

Pharma Education

IFF, after brief leadership stint under Merck's Frank Clyburn, pawns off pharma solutions business for $2.85B

Fierce Pharma

MARCH 19, 2024

New York's IFF—which dabbles in food, beverage, beauty and pharmaceutical supply chains, among others—has agreed to sell its pharma solutions business to French plant-based ingredient maker Roquette for up to $2.85 After a two-year stint under Merck & Co.

Pharma

Pharma Food Healthcare Healthcare

What to look for when hiring in pharma

World of DTC Marketing

AUGUST 15, 2022

The great resignation has not affected pharma because the jobs within the industry pay very well and most positions and employees like the benefit of having a steady job with good money. However, some pharma companies are having problems filling open positions, and when they do, they often find it wasn’t a good fit.

Pharma

Pharma Management Marketing

Will Big Pharma engage in Medicare price negotiations? The verdict's not in

Fierce Pharma

SEPTEMBER 27, 2023

Will Big Pharma engage in Medicare price negotiations? The verdict's not in zbecker Wed, 09/27/2023 - 10:40

Pharma

The tactical trap in pharma CX – and how to avoid it

Dominic Tyer

JUNE 25, 2024

Customer experience (CX) is not a new discipline for pharma, but it does continue to provide the industry with growing pains

Pharma

Pharma Consulting Marketing

Ahead of key Stelara patent cliff, J&J's pharma business churns out growth

Fierce Pharma

JANUARY 23, 2024

Ahead of key Stelara patent cliff, J&J's pharma business churns out growth fkansteiner Tue, 01/23/2024 - 11:32

Pharma

Ferring inks $500M deal with Royalty Pharma on new bladder cancer gene therapy

Fierce Pharma

AUGUST 24, 2023

Royalty Pharma has built a niche by finding innovative products pre- and post-approval from companies that need an infusion of cash in exchange for future royalties. Royalty Pharma has signed a deal with Ferring Pharmaceuticals to collect royalties on bladder cancer drug Adstiladrin.

Pharma

Pharma Manufacturing Sales Pharmaceutical

AstraZeneca completes Amolyt Pharma acquisition

Pharmaceutical Technology

JULY 16, 2024

AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases.

Pharma

Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease

Fierce Pharma

JUNE 20, 2023

Paired with statins, the once-daily tablet—formulated from the ancient therapy colchicine—has been shown to reduce the risk of stroke and cardiovascular death by 31%.

Pharma

Pharma FDA

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

Fierce Pharma

FEBRUARY 3, 2023

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries mbayer Fri, 02/03/2023 - 09:29

Pharma

EU plots major pharma reforms—but industry is already pushing back

Fierce Pharma

APRIL 28, 2023

EU plots major pharma reforms—but industry is already pushing back zbecker Fri, 04/28/2023 - 18:04

Pharma

Pfizer, AstraZeneca run it back in IDEA Pharma's annual innovation rankings

Fierce Pharma

MAY 8, 2023

Pfizer, AstraZeneca run it back in IDEA Pharma's annual innovation rankings kdunleavy Mon, 05/08/2023 - 10:21

Pharma

Pharma Horizons: Formulation

European Pharmaceutical Review

JULY 19, 2024

This Pharma Horizons report is brought to you in association with: The post Pharma Horizons: Formulation appeared first on European Pharmaceutical Review. Interested? Register your details now to download for free today!

Pharma

Pharma Manufacturing Safety Pharmaceutical

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

JANUARY 24, 2024

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. The post Pharma Horizons: Artificial Intelligence appeared first on European Pharmaceutical Review.

Pharma

Pharma Pharmaceutical manufacturing Manufacturing Pharmaceutical

Apellis Pharma and its rare disease, eyecare drugs draw takeover interest: Bloomberg

Fierce Pharma

APRIL 3, 2023

Apellis Pharma and its rare disease, eyecare drugs draw takeover interest: Bloomberg zbecker Mon, 04/03/2023 - 11:00

Pharma

Fierce Pharma Asia—China's reimbursement round; Sun's alopecia bet; GenScript's CDMO raise

Fierce Pharma

JANUARY 19, 2023

Fierce Pharma Asia—China's reimbursement round; Sun's alopecia bet; GenScript's CDMO raise aliu Thu, 01/19/2023 - 15:53

Pharma

Cycle Pharma makes $466m takeover bid for Vanda

pharmaphorum

JUNE 7, 2024

UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma, which is already fending off an overture from Future Pak.

Pharma

European big pharmas raise guidance on stronger sales

pharmaphorum

JULY 25, 2024

European pharma groups AstraZeneca, Sanofi, and Roche all raise their financial guidance for the year on stronger sales growth.

Sales

Sales Pharma

Fierce Pharma Asia—Carvykti's massive myeloma win; BeiGene's PD-1 comeback

Fierce Pharma

APRIL 20, 2023

Fierce Pharma Asia—Carvykti's massive myeloma win; BeiGene's PD-1 comeback aliu Thu, 04/20/2023 - 15:00

Pharma

Senate unanimously endorses legislation targeting pharma 'patent thickets'

Grünenthal continues US growth push with $250M acquisition of Valinor Pharma

Trending Sources

Fierce Pharma Asia—Hengrui's FDA reprimands; Sanofi's India site expansion; Aslan's downfall

Pharma companies report different impacts from IT outrage caused by CrowdStrike, Microsoft

Bayer to largely complete layoffs within pharma commercial team in 2024, exec says

Fierce Pharma Asia—Big Pharma's search for China deals; Enhertu slowdown; A Samsung Bio record

Using AI to Become Pharma's Next Superhero

NS Pharma's Duchenne therapy Viltepso fails confirmatory trial

Executive Interviews at Digital Pharma East 2023

Fierce Pharma Asia—AbbVie's TL1A deal; Ex-Takeda staffer's guilty plea; Kyowa Kirin's $530M plant investment

Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced

Leo Pharma prepares to come for the topical JAK market as Incyte's Opzelura cream launch cools off

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

2024 forecast: Big Pharma reworks China strategy, and job cuts are part of it

Pharma marketing: Getting personalized with Fingerpaint Group

Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans

Tris Pharma captures FDA nod for non-stimulant ADHD treatment Onyda XR

With exec appointments and new pharma unit, Bayer's overhaul takes shape

Eying Incyte's Opzelura, Leo Pharma shares data for JAK cream in hand eczema

Fierce Pharma Asia—Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament

Fierce Pharma Asia—Plant expansions at Novo, Novartis, Merck KGaA; Kyowa Kirin's pricing record; BeiGene's PD-1 nod

'The Top Line': A look at pharma revenue rankings

J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings

Vanda, after rejecting Future Pak offer, gets $466M takeout bid from Cycle Pharma

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Novo attempts to parry Sanders' GLP-1 pricing complaints by calling out pharma middlemen

IFF, after brief leadership stint under Merck's Frank Clyburn, pawns off pharma solutions business for $2.85B

What to look for when hiring in pharma

Will Big Pharma engage in Medicare price negotiations? The verdict's not in

The tactical trap in pharma CX – and how to avoid it

Ahead of key Stelara patent cliff, J&J's pharma business churns out growth

Ferring inks $500M deal with Royalty Pharma on new bladder cancer gene therapy

AstraZeneca completes Amolyt Pharma acquisition

Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

EU plots major pharma reforms—but industry is already pushing back

Pfizer, AstraZeneca run it back in IDEA Pharma's annual innovation rankings

Pharma Horizons: Formulation

Pharma Horizons: Artificial Intelligence

Apellis Pharma and its rare disease, eyecare drugs draw takeover interest: Bloomberg

Fierce Pharma Asia—China's reimbursement round; Sun's alopecia bet; GenScript's CDMO raise

Cycle Pharma makes $466m takeover bid for Vanda

European big pharmas raise guidance on stronger sales

Fierce Pharma Asia—Carvykti's massive myeloma win; BeiGene's PD-1 comeback

Stay Connected